Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial and astrocyte metabolic machinery refers to the complex, integrated system of energy production and substrate exchange between glial cells and neurons in the central nervous system. Astrocytes facilitate neuronal function by performing glycolysis and exporting lactate via monocarboxylate transporters (MCTs) to neurons, which then utilize it for oxidative phosphorylation within their mitochondria, a process known as the astrocyte-neuron lactate shuttle (ANLS) [1][4]. Mitochondria within this machinery are responsible for ATP synthesis, calcium buffering, and the regulation of apoptotic pathways [2]. Dysregulation of these metabolic processes is a primary driver of neurodegeneration, as seen in Alzheimer's and Parkinson's diseases, where impaired glucose utilization and mitochondrial failure lead to synaptic loss [3]. While specific components like Complex I or MCTs are targeted by drugs, the machinery as a whole is a physiological system rather than a single therapeutic target [5]. Therapeutic interventions often focus on restoring metabolic flexibility or reducing the oxidative damage associated with mitochondrial dysfunction [2][3]. Sources: [1] Pellerin L, Magistretti PJ. (2012). "Sweeten your memories: the role of the astrocyte-neuron lactate shuttle in memory formation." Frontiers in Integrative Neuroscience. [2] Murphy AN, Fiskum G. (2001). "Mitochondrial function and dysfunction in the central nervous system." Life Sciences. [3] Lin MT, Beal MF. (2006). "Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases." Nature. [4] Bélanger M, et al. (2011). "Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation." Cell Metabolism. [5] Pathak D, et al. (2015). "The role of mitochondrial morphology and dynamics in activity-dependent synaptic repair." Frontiers in Cellular Neuroscience.
Modulation of mitochondrial respiratory chain complexes, enhancement of monocarboxylate transporter (MCT) activity, and regulation of reactive oxygen species (ROS) production to maintain neuronal ATP levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial and astrocyte metabolic machinery.